PRN: Two Day Seminar US GCP Fundamentals for Pharmaceutical and Biologic Companies - San Francisco, CA, United States - April 20-21, 2017 - Research and Markets

15/mar/2017 12:45:14 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Two Day Seminar US GCP Fundamentals for Pharmaceutical and Biologic Companies - San Francisco, CA, United States - April 20-21, 2017 - Research and Markets


DUBLIN, Mar 15, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "US GCP Fundamentals for Pharmaceutical and Biologic Companies" conference to their offering.

Research and Markets Logo

This seminar provides an introduction to GCP, with emphasis on the regulations governing drug and biologic clinical trials. (Most of the information is also applicable to medical devices, but specific requirements for device trials are not discussed.) It also covers the essential elements of FDA inspections of Sponsors and CROs, clinical trial sites, and IRBs, provides guidance for how to effectively prepare for and manage these inspections, and how to communicate effectively with the FDA about inspection outcomes.

Since many companies operate clinical trials in a variety of world-wide venues, the course provides an introduction to key guidelines for GCP from the International Conference on Harmonization (ICH), which are used by multiple health regulatory authorities as definitive guidance for GCP compliance. The primary emphasis, however, is placed on FDA requirements.

Learning Objectives:

- Understand the meaning of the term Good Clinical Practice (GCP)
- Know which FDA regulations constitute GCP
- Know the requirements the regulations place on Sponsors, CROs, clinical trial sites and IRBs
- Understand the basic elements of informed consent
- Understand the rules for avoidance of financial conflict of interest by clinical investigators
- Understand the applicability of Good Manufacturing Practice to the production of clinical trial materials
- Understand why inventory control and reconciliation is important to GCP compliance
- Understand the criticality of data integrity and the prevention and detection of fraud and misconduct in clinical trials
- Understand the basics of FDA inspection management, and how to find key guidance resources to prepare for and manage FDA GCP inspections
- Understand the role of ICH guidelines in GCP compliance

Who Should Attend:

- Clinical Operations Staff
- Clinical QA Staff
- Clinical Research Associates
- CRO Employees involved in the above areas
- Regulatory Affairs professionals
- Clinical Auditors
- GMP Professionals who need to understand GCP requirements
- Clinical trial site coordinators

For more information about this conference visit

Media Contact:

Laura Wood, Senior Manager 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl